The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality from COVID-19

Mostrar otras versiones (1)

Effective therapies for coronavirus disease 2019 (COVID-19) are urgently needed, and preclinical data suggest alpha-1 adrenergic receptor antagonists (α(1)-AR antagonists) may be effective in reducing mortality related to hyperinflammation independent of etiology. Using a retrospective cohort design...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Liam, Graham, Laura, Koenecke, Allison, Powell, Michael, Xiong, Ruoxuan, Shen, Zhu, Kinzler, Kenneth W., Bettegowda, Chetan, Vogelstein, Bert, Athey, Susan, Vogelstein, Joshua T., Konig, Maximilian F., Wagner, Todd H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781337/
https://www.ncbi.nlm.nih.gov/pubmed/33398294
http://dx.doi.org/10.1101/2020.12.18.20248346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781337/
https://www.ncbi.nlm.nih.gov/pubmed/33398294
http://dx.doi.org/10.1101/2020.12.18.20248346

Ejemplares similares